期刊文献+

前列地尔联合血栓通治疗下肢动脉硬化闭塞症的临床观察 被引量:16

Clinical observation of Alprostadil and Xueshuantong in treatment of lower limb arteriosclerosis occlusion
原文传递
导出
摘要 目地观察前列地尔(凯时)联合血栓通(晨钟)治疗双下肢动脉硬化闭塞症的临床疗效。方法将郑州大学第五附属医院2009年1月至2011年1月收治的双下肢动脉硬化闭塞症82例,随机分为2组,在常规治疗基础上,对照组予0.9%氯化钠100ml加前列地尔20μg静脉滴注,观察组在对照组基础上联合0.9%氯化钠100ml加血栓通针0.5g静脉滴注,每日1次,疗程为14d。疗程结束后评定疗效。结果观察组的有效率为97.56%,对照组的有效率为80.49%,两组比较差异有统计学意义(P<0.05)。两组治疗后的踝臂指数、趾肱指数(ABI、TBI)较治疗前比较,差异有统计学意义(P<0.05),且观察组踝臂指数、趾肱指数(ABI、TBI)变化较对照组显著(P<0.05)。结论前列地尔联合血栓通治疗下肢动脉硬化闭塞症可有效改善患者的症状,提高临床疗效,且不良反应轻微。 Objective To observe the clinical effect of Alprostadil and Xueshuantong in treatment of the lower limb arteriosclerosis occlusion.Methods The Fifth Affiliated Hospital of Zhengzhou University from January 2009 to January.2011,lower limb arteriosclerosis block 82 cases of disease,were randomly divided into two groups,based on the conventional treatment,control group to give Alprostadil intravenous drip,based on the observation group in the control group joint Xueshuantong intravenous drip,qd,treatment for 14d.Evaluated results after the course.Results The effective rate in observation group was 97.56%,the control group was 80.49%,two groups of comparisons difference have statistical significance(P0.05).Two groups after treating ABI and TBI is before treatment compared,difference have statistical significance(P0.05),and the observation group ABI,TBI was significantly with the change(P0.05).Conclusions Alprostadil joint Xueshuantong treatment of lower limb arteriosclerosis block disease can effectively improve the symptoms of patients,improve the clinical effect,and slightly adverse reactions.
出处 《医药论坛杂志》 2012年第1期4-6,共3页 Journal of Medical Forum
关键词 前列地尔 血栓通 下肢动脉硬化闭塞症 Alprostadil Xueshuantong The lower limb arteriosclerosis occlusion of the disease
  • 相关文献

参考文献7

二级参考文献33

  • 1畅坚,许樟荣,王志强,陈平,杨丽娜.糖尿病与非糖尿病患者外周动脉病变血管造影对比研究[J].中华糖尿病杂志(1006-6187),2004,12(5):324-327. 被引量:75
  • 2三岛好雄 现代医疗编集委员会.外科:血管外科[M].东京:现代医疗社,1984.264. 被引量:1
  • 3[1]Ouriel K. Peripheral artery disease. Lancet , 2001, 358 :1257-1264. 被引量:1
  • 4[3]Diabeted drafting group. Prevalence of small and large vessel disease in diabetic patients from 14 centers. The WTO multinational study of vascular disease in diabetics. Diabetologia,1985,28(Suppl): 615-640. 被引量:1
  • 5[4]Jude EB, Chalmers NC, Oyibo SO, et al. Peripheral arterial disease in diabetic and nondiabetic patients - a comparison of severity and outcome. Diabetes Care, 2001,24:1433-1437. 被引量:1
  • 6[7]Toyata T,Hirata Y. Lipo-PGE1 ,a new lipidencapsulated preparation of prostaglandin E1 placebo and prostaglandin E1-eontrolled multi center trials in patients with diabetic neuropathy and leg ulcers. Prostaglandins, 1993,46:453. 被引量:1
  • 7[8]Makino H, Aoki M, Hashiya N, et al. Increase in peripheral blood flow by intravenous administration of prostaglandin E1 in patients with peripheral arterial disease, accompanied by upregulation of hepatocyte growth factor. Hypertens Res, 2004,27:85-91. 被引量:1
  • 8[9]Mlekusch W, Schillinger M, Sabeti S, et al. Effects of intravenous prostaglandin E1 on arterial compliance: a randomized controlled trial. Vasa,2004, 33:131-136. 被引量:1
  • 9Watkins PJ.Clinica la observations and experiments in diabetic Neuropathy diabelogia,1992,35. 被引量:1
  • 10刘德辉.糖尿病足坏疽发生机理的探讨[J].中国病理生理杂志,1996,12(5):539-539. 被引量:9

共引文献167

同被引文献148

引证文献16

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部